Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is lipid peroxidation relevant to atherogenesis?

Literature DB >> 10411541

Is lipid peroxidation relevant to atherogenesis?

J W Heinecke.

Abstract

Entities: Chemical

Mesh：

Substances：
Lipoproteins, LDL

Year: 1999 PMID： 10411541 PMCID： PMC408481 DOI： 10.1172/JCI7633

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

24 in total

Review 1. Role of oxidized low density lipoprotein in atherogenesis.

Authors: J L Witztum; D Steinberg
Journal: J Clin Invest Date: 1991-12 Impact factor: 14.808

Review 2. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

Authors: M Navab; J A Berliner; A D Watson; S Y Hama; M C Territo; A J Lusis; D M Shih; B J Van Lenten; J S Frank; L L Demer; P A Edwards; A M Fogelman
Journal: Arterioscler Thromb Vasc Biol Date: 1996-07 Impact factor: 8.311

3. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.

Authors: C Leeuwenburgh; J E Rasmussen; F F Hsu; D M Mueller; S Pennathur; J W Heinecke
Journal: J Biol Chem Date: 1997-02-07 Impact factor: 5.157

4. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.

Authors: S H Zhang; R L Reddick; E Avdievich; L K Surles; R G Jones; J B Reynolds; S H Quarfordt; N Maeda
Journal: J Clin Invest Date: 1997-06-15 Impact factor: 14.808

5. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

Authors: N G Stephens; A Parsons; P M Schofield; F Kelly; K Cheeseman; M J Mitchinson
Journal: Lancet Date: 1996-03-23 Impact factor: 79.321

6. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.

Authors: A D Watson; N Leitinger; M Navab; K F Faull; S Hörkkö; J L Witztum; W Palinski; D Schwenke; R G Salomon; W Sha; G Subbanagounder; A M Fogelman; J A Berliner
Journal: J Biol Chem Date: 1997-05-23 Impact factor: 5.157

Review 7. Antioxidants and atherosclerotic heart disease.

Authors: M N Diaz; B Frei; J A Vita; J F Keaney
Journal: N Engl J Med Date: 1997-08-07 Impact factor: 91.245

8. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

Authors: J Fruebis; D Steinberg; H A Dresel; T E Carew
Journal: J Clin Invest Date: 1994-07 Impact factor: 14.808

9. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.

Authors: G M Chisolm; G Ma; K C Irwin; L L Martin; K G Gunderson; L F Linberg; D W Morel; P E DiCorleto
Journal: Proc Natl Acad Sci U S A Date: 1994-11-22 Impact factor: 11.205

10. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

Authors: H A Kleinveld; P N Demacker; A F Stalenhoef
Journal: Arterioscler Thromb Date: 1994-08

4 in total